Regeneron turns to IT to accelerate drug discovery
CIO Business Intelligence
NOVEMBER 4, 2022
The company’s multicloud infrastructure has since expanded to include Microsoft Azure for business applications and Google Cloud Platform to provide its scientists with a greater array of options for experimentation. Much of Regeneron’s data, of course, is confidential. That’s hard to do when you have 30 years of data.”
116 
Let's personalize your content